Casandra
Casandra Test Code PG18262Version 1 (DRAFT)
Performing Lab
Hemophilia C via the F11 Gene
Clinical Use
Order TestUse
This test is intended for individuals with relevant features who have a clinical or suspected diagnosis of Hemophilia C. It is also suitable for reproductive partners of individuals with a known pathogenic variant in the F11 gene. The test helps in diagnosing and managing Hemophilia C by identifying genetic variants in the F11 gene.
Special Instructions
Not provided.
Limitations
This test focuses solely on the F11 gene and may not detect all genetic variants associated with Hemophilia C or other bleeding disorders. The test has not been cleared or approved by the FDA and is not New York state approved. Test performance is validated under CAP and CLIA regulations.
Test Details
Methodology
NGS (Targeted)
Biomarkers
F11 Gene Sequencing • Targeted
Result Turnaround Time
2-3 weeks
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided